Patent · US Active

Anti-CD33 antibodies and immunoconjugates

US9951133B2 · kind B2 · utility

10Cited by
0References
51Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 2, 2016
Grant dateApr 24, 2018
Priority date
Expiry dateJun 2, 2036

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2458/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides anti-CD33 antibodies and immunoconjugates and methods of using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.